Items where authors include "Gillgrass, L."

Article

Caley, L.R. orcid.org/0000-0001-8957-1018, Gillgrass, L., Zagoya, C. et al. (5 more authors) (2025) Longer term follow-up of abdominal symptoms (CFAbd-Score) after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis. Journal of Cystic Fibrosis, 24 (4). pp. 787-791. ISSN 1569-1993

Whitaker, P., Gibson, A., Farrell, J. et al. (4 more authors) (2025) Prospective piperacillin lymphocyte transformation testing in patients with cystic fibrosis receiving regular and desensitization courses of piperacillin-tazobactam. The Journal of Allergy and Clinical Immunology: In Practice, 13 (3). pp. 594-609. ISSN 2213-2198

Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Gillgrass, L., Caley, L.R. orcid.org/0000-0001-8957-1018 et al. (6 more authors) (2024) Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del. PLOS ONE, 19 (5). e0304555. ISSN 1932-6203

Proceedings Paper

Gillgrass, L., Caley, L. orcid.org/0000-0001-8957-1018, Zagoya, C. et al. (5 more authors) (2024) P318 Abdominal symptoms after longer term use of elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis. In: Journal of Cystic Fibrosis. 47th European Cystic Fibrosis Conference, 05 Jun 2024 - 08 Jun 2025, Glasgow, UK. Elsevier .